Trupanion (NASDAQ:TRUP – Free Report) had its price objective reduced by Stifel Nicolaus from $44.00 to $41.00 in a research report sent to investors on Thursday,Benzinga reports. They currently have a hold rating on the financial services provider’s stock.
A number of other equities analysts have also commented on the stock. Northland Securities boosted their price target on shares of Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Piper Sandler reduced their price target on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research report on Thursday. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $46.60.
Check Out Our Latest Stock Report on TRUP
Trupanion Price Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The firm had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. As a group, research analysts expect that Trupanion will post -0.2 EPS for the current fiscal year.
Insiders Place Their Bets
In other Trupanion news, SVP Emily Dreyer sold 900 shares of the business’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $54.55, for a total value of $49,095.00. Following the completion of the transaction, the senior vice president now directly owns 23,808 shares of the company’s stock, valued at approximately $1,298,726.40. The trade was a 3.64 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Fawwad Qureshi sold 622 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total transaction of $32,723.42. Following the completion of the transaction, the chief financial officer now directly owns 9,867 shares of the company’s stock, valued at approximately $519,102.87. This represents a 5.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 11,581 shares of company stock valued at $615,159. Insiders own 5.50% of the company’s stock.
Institutional Investors Weigh In On Trupanion
Institutional investors and hedge funds have recently modified their holdings of the business. SBI Securities Co. Ltd. bought a new stake in shares of Trupanion during the fourth quarter worth approximately $25,000. Jones Financial Companies Lllp raised its stake in shares of Trupanion by 71.7% during the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider’s stock worth $27,000 after buying an additional 238 shares during the last quarter. Quarry LP bought a new stake in shares of Trupanion during the fourth quarter worth approximately $39,000. Quest Partners LLC bought a new stake in shares of Trupanion during the third quarter worth approximately $37,000. Finally, Aster Capital Management DIFC Ltd raised its stake in shares of Trupanion by 988.5% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,132 shares of the financial services provider’s stock worth $55,000 after buying an additional 1,028 shares during the last quarter.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Featured Stories
- Five stocks we like better than Trupanion
- What Are Dividend Contenders? Investing in Dividend Contenders
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- The Basics of Support and Resistance
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.